ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_9_length_70440_cov_4.6979_34 # 50859 # 51182 # 1 # ID=9_34;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556	NODE_9_length_70440_cov_4.6979_34 	50859	51182	+	Strict	1000	22.7126	lsaA	100.0	3000300	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAGGCGGGGTGTCCCTCCGGCTGGTTGTACTGGGCTAGTATTGACCGGTTGGGGGAGTGGCGCCCCGCTTTTTGTGCCTTCGCTTTTTGCGCCTCTATCTTTTTCGATTCTGCCCGCATGTGCTGCCCTCATGCTCCCACTCGAACACATGCACTCTCACGTGTTTCCATGTGCTCTCACCTACCCCCAATCGCTCAAATTCAACCGGCATCGCTCACCCTCACTCACCCAAACCCACCCAAAAATCGAAAAGAACGAAAATTTTCGGGCATCGGGGTACAAAACCGGGCACGCCGTCGCGTCTCGGTGCTATATTCGCTGA	MRRGVPPAGCTGLVLTGWGSGAPLFVPSLFAPLSFSILPACAALMLPLEHMHSHVFPCALTYPQSLKFNRHRSPSLTQTHPKIEKNENFRASGYKTGHAVASRCYIR	MSKIELKQLSFAYDNQEVLLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWELERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGNFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFAPLSFSINAGEIVGITGKNGSGKSSLIQYLLDNFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVKPAMLVIEHDAHFMKKITDKKIVLKS	21.49	gnl|BL_ORD_ID|1244|hsp_num:0	1298
NODE_174_length_10773_cov_5.99272_6 # 1805 # 3268 # -1 # ID=174_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_174_length_10773_cov_5.99272_6	1805	3268	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_174_length_10773_cov_5.99272_7 # 3388 # 4605 # -1 # ID=174_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_174_length_10773_cov_5.99272_7 	3388	4605	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_353_length_8062_cov_3.37817_9 # 7909 # 8061 # 1 # ID=353_9;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	NODE_353_length_8062_cov_3.37817_9 	7909	8061	+	Strict	375	20.0162	tmrB	100.0	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	ATGTCTATACTGAATACTATGAAACGTCGTCTGAAAAATGGCGGTAGCGGTAAAACACAGACTGCAAAGGCGGCGCAAGCCGATTCTTTATTGCGTCTGTTGGTGGCGTTTATCCTGATTGTGGTTTTGTTTGCCGCATTGGTGGCGCGGTTT	MSILNTMKRRLKNGGSGKTQTAKAAQADSLLRLLVAFILIVVLFAALVARF	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	25.89	gnl|BL_ORD_ID|1718|hsp_num:0	1794
NODE_419_length_7455_cov_2.93514_1 # 2 # 142 # -1 # ID=419_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.284	NODE_419_length_7455_cov_2.93514_1 	2	142	-	Strict	250	99.3673	tet(D)	100.0	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTATATTGAACAGCATTCTCGCTATCAAAATAAAGCTAATAACATCCAATTAAGATATGATGATAAGCAGTTTCATACAACGGTTATCAAAGATGTTCTATTATGGATTGAACATAATTTAGATCAGTCTTTACTGCTT	MYIEQHSRYQNKANNIQLRYDDKQFHTTVIKDVLLWIEHNLDQSLLL	MYIEQHSRYQNKANNIQLRYDDKQFHTTVIKDVLLWIEHNLDQSLLLDDVANKAGYTKWYFQRLFKKVTGVTLASYIRARRLTKAAVELRLTKKTILEIALKYQFDSQQSFTRRFKYIFKVTPSYYRRNKLWELEAMH	34.06	gnl|BL_ORD_ID|1239|hsp_num:0	1138
NODE_419_length_7455_cov_2.93514_3 # 951 # 2156 # -1 # ID=419_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.432	NODE_419_length_7455_cov_2.93514_3	951	2156	-	Perfect	600	790.03	tet(A)	100.0	3000165	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATAGTTCGACAAAGATCGCATTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACACGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	100.00	gnl|BL_ORD_ID|1858|hsp_num:0	1808
NODE_479_length_7054_cov_3.22546_4 # 1796 # 2611 # 1 # ID=479_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.436	NODE_479_length_7054_cov_3.22546_4	1796	2611	+	Strict	500	560.066	APH(3')-Ia	98.52	3002641	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCAGTTTCATTTGATGCTCGATGAGTTTTTCTAA	MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGSVANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF	100.00	gnl|BL_ORD_ID|272|hsp_num:0	291
NODE_479_length_7054_cov_3.22546_8 # 6714 # 7052 # 1 # ID=479_8;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.619	NODE_479_length_7054_cov_3.22546_8 	6714	7052	+	Loose	730	106.686	tet(G)	52.83	3000174	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCTTGAGAGCCTTCAACCCAGTCAGCTCCTTCCGGTGGGCGCGGGGCATGACTATCGTCGCCGCACTTATGACTGTCTTCTTTATCATGCAACTCGTAGGACAGGTGCCGGCAGCGCTCTGGGTCATTTTCGGCGAGGACCGCTTTCGCTGGAGCGCGACGATGATCGGCCTGTCGCTTGCGGTATTCGGAATCTTGCACGCCCTCGCTCAAGCCTTCGTCACTGGTCCCGCCACCAAACGTTTCGGCGAGAAGCAGGCCATTATCGCCGGCATGGCGGCCCCACGGGTGCGCATGATCGTGCTCCTGTCGTTGAGGACCCGGCTAGGCTGGCGG	MPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAAPRVRMIVLLSLRTRLGWR	MRSSAIIALLIVGLDAIGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVCAPLLGQFSDGYGRRPVLLASLAGAAVDYTIMASAPVLWVLYIGRLISGITGATGAVAASTIADSTGEGSRARWFGYMGACYGTGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETNRSHGETGKLVRIEPFVLFRLDDALRGLTALFAVFFTIQLIGQVPAALWVIYGEDRFQWDTTTVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFILLAFATQGWMVFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATIGAWTGWVWIVGAILYLICLPILRRPFATSL	28.90	gnl|BL_ORD_ID|930|hsp_num:0	957
NODE_1288_length_4261_cov_1.74964_5 # 3253 # 3438 # -1 # ID=1288_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.543	NODE_1288_length_4261_cov_1.74964_5 	3253	3438	-	Loose	300	21.9422	vanI	43.48	3003723	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGCCAAATCTGCCGCGCGAAAAAATCTTTTCTTTCGCCGCCTCGCTCTCCTCCGCCGCAAAAGTGGTGGACTTTCGCGCGAAAGCAGTGGACTTTCGGCAAAAAGTGGACTGCTTTTTGCCGAAAGTCGTCGAAAAACGCCTTTCCCACGGCTTCTTTCGCGCCACTCTTCTCCTCGGCGCTTGA	MPNLPREKIFSFAASLSSAAKVVDFRAKAVDFRQKVDCFLPKVVEKRLSHGFFRATLLLGA	PKFRTVTAKETIDAERLAYPVYVKPARSGSSFGVTKVCRQEELLSAVEIARQYDSKVLIEEAVVGSEVGCAIFGNDLDLMAGEVDQICLSHGFFRIHQENEPEKGSENSTLIVPADISPEARSRVQETAKAIYRALGCRGLARVDMFLKEDGTVILNEVNTLPGMTSYSR	35.88	gnl|BL_ORD_ID|2116|hsp_num:0	2241
NODE_1344_length_4175_cov_2.17913_3 # 2139 # 2939 # -1 # ID=1344_3;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.340	NODE_1344_length_4175_cov_2.17913_3	2139	2939	-	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_2162_length_3235_cov_1.90566_6 # 3175 # 3234 # 1 # ID=2162_6;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.333	NODE_2162_length_3235_cov_1.90566_6 	3175	3234	+	Loose	650	18.8606	vanG	53.85	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGTGGATGGAAGAATTGCCAAATGGCAAGTTTAAATATTTTGAGCGATATAAAGATCCA	MWMEELPNGKFKYFERYKDP	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	5.73	gnl|BL_ORD_ID|1110|hsp_num:0	1157
NODE_2275_length_3144_cov_9.46131_3 # 3069 # 3143 # 1 # ID=2275_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.413	NODE_2275_length_3144_cov_9.46131_3 	3069	3143	+	Loose	450	18.4754	ANT(9)-Ia	50.0	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGACTTATCTCTCAGCGATTTATAGTGGATTAAATTTAAATCAGGACAAGGCGACGAAGCCGCAGACAGTACAG	MTYLSAIYSGLNLNQDKATKPQTVQ	MLIGVYLYGSAVMGGLRMNSDVDILVITNQSLSEKTRRNLTNRLMLISGKIGNIKDMRPLEVTVINQKDIVPWHFPPKYEFMYGEWLREQFEKGEIPESTYDPDLAILLAQLRKNSINLLGPKATEVIEPVPMTDIRKAIKESLPGLIASINGDERNVILTLARMWLTASTGEIRSKDLAAEWAIPQLPDEHATLLNKAREAYLGECVDKWEGMESEVAELVNHMKKSIESSLNIQLPFRIV	10.33	gnl|BL_ORD_ID|1321|hsp_num:0	1386
NODE_2320_length_3112_cov_2.56264_2 # 219 # 410 # 1 # ID=2320_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.458	NODE_2320_length_3112_cov_2.56264_2 	219	410	+	Strict	500	23.483	aad(6)	100.0	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGCGGTATATTCGCCGTACCAAACCAGATTGCCTTTGTCATCAGTTATTTCGCGCGGGATGTCGATTTGGTCGCAGTGGAAGTAGTGGGTTTGCTGGCGGTTTTGTCGTAGGCTTAGGCGAAGGTATGACCCAGCGCGTTGGTGAGAATAAATTATTTAAATACACTATACGTCGCCAATATAACACTTAG	MRYIRRTKPDCLCHQLFRAGCRFGRSGSSGFAGGFVVGLGEGMTQRVGENKLFKYTIRRQYNT	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	22.83	gnl|BL_ORD_ID|1489|hsp_num:0	1562
NODE_2994_length_2695_cov_5.29659_6 # 2531 # 2695 # -1 # ID=2994_6;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.673	NODE_2994_length_2695_cov_5.29659_6 	2531	2695	-	Loose	500	22.3274	OXA-22	37.5	3001417	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATCATCAACCTGGTCGTCTACGCACCCCTCCTGTGGGTCATCGCCCACTCCACCACGCTCACGGCACGCCCCTCGCTGGCTCTCGCGATGGTCTGGCTCGCCTACTCGGCCGTCTACACCGGCATGCGGGCCCTCACCAACGGGCTCGGCGCCCGCTCTCTGTAG	IINLVVYAPLLWVIAHSTTLTARPSLALAMVWLAYSAVYTGMRALTNGLGARSL	MKRRHAAIGALLAALATFAHAEHPICTIVADAATGKAVLHEGKCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGLMRRIVNRQLPVSAHTYEMLDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALFARLSEVLAFAGH	19.71	gnl|BL_ORD_ID|654|hsp_num:0	693
NODE_4008_length_2295_cov_2.13482_2 # 1000 # 1269 # 1 # ID=4008_2;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.381	NODE_4008_length_2295_cov_2.13482_2 	1000	1269	+	Strict	350	22.3274	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	TTGTTAGCTACTTTAGCAGATGTAGAAGCCATCAAAAAAAATCTCAAGAGTGTTGTTGAGGAAAATACAGCTCTTCGTTTAGAGAATGATAAACTTAGAGAACGCTTGAGTGAGGAAGAAGAAACTGTCCCAACTAAGACTAAACATGTCAGAGAAAACGTGAGTCGTATTTATGACGACGGATTTCATGTTTGTCGAGATTTTTATGGGCAACGTCGAGAGCAGGATGCAGAATGTATGTTCTGTGATGAATTGTTGTTTAGGGAGTAA	LLATLADVEAIKKNLKSVVEENTALRLENDKLRERLSEEEETVPTKTKHVRENVSRIYDDGFHVCRDFYGQRREQDAECMFCDELLFRE	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	43.00	gnl|BL_ORD_ID|790|hsp_num:0	823
NODE_4505_length_2144_cov_4.67736_1 # 75 # 878 # 1 # ID=4505_1;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.562	NODE_4505_length_2144_cov_4.67736_1	75	878	+	Strict	500	541.191	APH(3'')-Ib	99.63	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	TTGAATCGAACTAATATTTTTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACGTGGTGACGGGCATGCCTTCGCGAAAATCGCACCTGCTTCCCGCCGCGGTGAGCTCGCTGGAGAGCGTGACCGCCTCATTTGGCTCAAAGGTCGAGGTGTGGCTTGCCCCGAGGTGATCAACTGGCAGGAGGAACAGGAGGGTGCATGCTTGGTGATAACGGCAATTCCGGGAGTACCGGCGGCTGATCTGTCTGGAGCGGATTTGCTCAAAGCGTGGCCGTCAATGGGGCAGCAACTTGGCGCTGTTCACAGCCTATCGGTTGATCAATGTCCGTTTGAGCGCAGGCTGTCGCGAATGTTCGGACGCGCCGTTGATGTGGTGTCCCGCAATGCCGTCAATCCCGACTTCTTACCGGACGAGGACAAGAGTACGCCGCAGCTCGATCTTTTGGCTCGTGTCGAACGAGAGCTACCGGTGCGGCTCGACCAAGAGCGCACCGATATGGTTGTTTGCCATGGTGATCCCTGCATGCCGAACTTCATGGTGGACCCTAAAACTCTTCAATGCACGGGTCTGATCGACCTTGGGCGGCTCGGAACAGCAGATCGCTATGCCGATTTGGCACTCATGATTGCTAACGCCGAAGAGAACTGGGCAGCGCCAGATGAAGCAGAGCGCGCCTTCGCTGTCCTATTCAATGTATTGGGGATCGAAGCCCCCGACCGCGAACGCCTTGCCTTCTATCTGCGATTGGACCCTCTGACTTGGGGTTGA	LNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	100.00	gnl|BL_ORD_ID|1752|hsp_num:0	1830
NODE_4505_length_2144_cov_4.67736_2 # 878 # 1714 # 1 # ID=4505_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	NODE_4505_length_2144_cov_4.67736_2	878	1714	+	Strict	500	568.155	APH(6)-Id	99.64	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGTTCATGCCGCCTGTTTTTCCTGCTCATTGGCACGTTTCGCAACCTGTTCTCATTGCGGACACCTTTTCCAGCCTCGTTTGGAAAGTTTCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGCGCGGGGCCGACTATCTGGTATGGCGCAATGGGAGGGGAGCAGTCCGGTTGCTCGGTCGTGAGAACAATCTGATGTTGCTCGAATATGCCGGGGAGCGAATGCTCTCTCACATCGTTGCCGAGCACGGCGACTACCAGGCGACCGAAATTGCAGCGGAACTAATGGCGAAGCTGTATGCCGCATCTGAGGAACCCCTGCCTTCTGCCCTTCTCCCGATCCGGGATCGCTTTGCAGCTTTGTTTCAGCGGGCGCGCGATGATCAAAACGCAGGTTGTCAAACTGACTACGTCCACGCGGCGATTATAGCCGATCAAATGATGAGCAATGCCTCGGAACTGCGTGGGCTACATGGCGATCTGCATCATGAAAACATCATGTTCTCCAGTCGCGGCTGGCTGGTGATAGATCCCGTCGGTCTGGTCGGTGAAGTGGGCTTTGGCGCCGCCAATATGTTCTACGATCCGGCTGACAGAGACGACCTTTGTCTCGATCCTAGACGCATTGCACAGATGGCGGACGCATTCTCTCGTGCGCTGGACGTCGATCCGCGTCGCCTGCTCGACCAGGCGTACGCTTATGGGTGCCTTTCCGCAGCTTGGAACGCGGATGGAGAAGAGGAGCAACGCGATCTAGCTATCGCGGCCGCGATCAAGCAGGTGCGACAGACGTCATACTAG	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEEEQRDLAIAAAIKQVRQTSY	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	100.00	gnl|BL_ORD_ID|989|hsp_num:0	1031
NODE_4710_length_2087_cov_4.04478_8 # 1156 # 1434 # 1 # ID=4710_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.448	NODE_4710_length_2087_cov_4.04478_8 	1156	1434	+	Loose	400	31.187	QnrB40	23.08	3002755	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	ATGGAATGTAGTGGAGTGGTATTTAATGGAGTGAAAAGGAATGGAGTGAGGTGGAGTGGAAGGGTGGGGAGTGGAACGGAATGGAATGGAATCGAATGGAATGGAGTGAAGTGGAGTGGACTGGAATGGAATGGAGTGGAATGGAATGGAAAGGAGTGGAATGGAATGGAATTTATTGGAATGGAATGGAGTGGAATGGAATGGAATGGAGTGAAGTGTAATGGATTGGAGAGGAGTGCAATAGAGCAGGGAGGAATGGAGTGGAATGGAAAATCATAA	MECSGVVFNGVKRNGVRWSGRVGSGTEWNGIEWNGVKWSGLEWNGVEWNGKEWNGMEFIGMEWSGMEWNGVKCNGLERSAIEQGGMEWNGKS	NTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG	42.01	gnl|BL_ORD_ID|1211|hsp_num:0	1267
NODE_5450_length_1918_cov_2.43057_4 # 1682 # 1918 # -1 # ID=5450_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.430	NODE_5450_length_1918_cov_2.43057_4 	1682	1918	-	Loose	700	24.6386	ADC-3	30.26	3003849	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	GGAGTAGTGGTCGTGGCTTTTGCAGCATTCTTCTACTTTAACCGAGAAAATGCACTCTTGTCGTTCAAACCGTTCCAATTTGCGACGTTTAACGCGACATTATATATCGTCCTAGCTTTCCAAGGAATGGTACTAGGATTATCGTTTATTTATCCAAACTACATTCAATTAGCGTGGGGCGAAACAAAACAGCCACAGTGGCAGGGCTCTTTATGTTTCCTGGAGCTGCGATGGTAG	GVVVVAFAAFFYFNRENALLSFKPFQFATFNATLYIVLAFQGMVLGLSFIYPNYIQLAWGETKQPQWQGSLCFLELRW	MRFKKISCLLLSPLFFFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIYANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLSAIKK	20.37	gnl|BL_ORD_ID|2181|hsp_num:0	2336
NODE_5865_length_1829_cov_4.5637_2 # 225 # 1079 # 1 # ID=5865_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.564	NODE_5865_length_1829_cov_4.5637_2	225	1079	+	Strict	400	442.965	ErmX	99.09	3000596	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTCTGCATACGGACACGGCCGTCACGAGCATGGCCAAAATTTTCTCACCAACCACAAGATCATCAACTCCATCATCGACCTTGTGAAACAAACCTCCGGCCCCATCATTGAGATCGGACCAGGAAGCGGTGCCCTCACTCACCCGATGGCCCACTTGGGGAGGGCGATAACGGCAGTTGAAGTGGACGCAAAACTAGCTGCCAAAATCACACAAGAAACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGTCATTGTGGGAAACATTCCCTTTCACCTCACCACTGCCATTCTTCGAAAGTTGCTGCATGCGCCAGCATGGACTGACGCTGTACTCCTCATGCAGTGGGAAGTCGCTCGCCGCCGGGCCGGGGTAGGCGCAAGCACGATGATGACGGCTCAGTGGTCCCCATGGTTCACATTTCACCTGGGTTCTCGGGTACCAAGGCCTGCTTTCCGGCCACAGCCAAACGTTGACGGGGGGATCTTAGTGATCCGCCGGGTGGGTGACCCGAAGATTCCGATAGAGCAGCGCAAAGCCTTTCAGGCGATGGTGCACACCGTTTTCACTGCCCGGGGACGCGGGATAGGGGAAATTCTCCGAAGGGCAGGGTTGTTTTCATCACGTTCAGAAACACAATCATGGTTGCGCTCGCGAGGAATCGACCCCGCGACCCTACCTCCCAGATTGCACACCAACGACTGGATCGATCTCTTCCAGGTGACTGGTTCCTCTCTACCTCACCATCGACCCATTTCACCATCGGGAAGTAGTCAACGACCTCCTCAACGGAAAAACCGAAGCCGGCGGCGTTAA	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRAGLFSSRSETQSWLRSRGIDPATLPPRLHTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR	MSAYGHGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAVEVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAWTDAVLLMQWEVARRRAGVGASTMMTAQWSPWFTFHLGSRVPRPAFRPQPNVDGGILVIRRVGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYLPDCTPTTGSISSR	112.25	gnl|BL_ORD_ID|908|hsp_num:0	950
NODE_5922_length_1818_cov_2.25695_3 # 1743 # 1817 # -1 # ID=5922_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.600	NODE_5922_length_1818_cov_2.25695_3 	1743	1817	-	Loose	400	18.8606	QnrA6	36.84	3002712	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GACACCCGCTTTAGGAGAGCGGTGCTCTATCCCCTGAGCTACGAGGGCGTGACACTTTGTCCGGGCCAACTCTAG	DTRFRRAVLYPLSYEGVTLCPGQL	MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD	11.01	gnl|BL_ORD_ID|1599|hsp_num:0	1673
NODE_6361_length_1747_cov_2.83747_2 # 337 # 894 # 1 # ID=6361_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.394	NODE_6361_length_1747_cov_2.83747_2 	337	894	+	Loose	500	24.6386	OXA-325	52.63	3001513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTTAAAGAGAGATTTACTAAGGAATATTATCATTGTGACGGTATTTATTGCCATTTTGGTGGGCTTACGTTTGTTTGTCTATACACCTTATCGTATCACCAAGCAGGATGCCAATTCTTTCTTAGCGGAGAATGATTTGGTCTTGGCAGATAAGACGGCTAAGCTTGTGCGTGGGGAATTTGCCCTCTATGAAGTCGATGGAAAAGAGTATGTCGGCCGTGTCATTGCTAAGGAAAATGACAAGGTGACCTATATGGATAACTTGCTGTATCTGAACGATCAGGTGCAATCAGAGCAATATATCGAAAAGATGCGAGAGAAATATCTGGCTTCGGCTACCAGCACGGGCTATTATACCCACGATTTTTCTGTTGTTGACTTAAAAGGAGCGACTTCTGATACCATCCCTAAAAATTCTTTTCTCATCTTGAATGATCGACGCGAAAATACGAAAGACAGTCGAGAATTTGGTCTGATCAAAAAGGAGAAGATTAAGGGAATTGTAGAATTCCGTATTTCTCCCTTAAATAAATTTGGTTTTGTTGAAACAAAGTAG	MLKRDLLRNIIIVTVFIAILVGLRLFVYTPYRITKQDANSFLAENDLVLADKTAKLVRGEFALYEVDGKEYVGRVIAKENDKVTYMDNLLYLNDQVQSEQYIEKMREKYLASATSTGYYTHDFSVVDLKGATSDTIPKNSFLILNDRRENTKDSREFGLIKKEKIKGIVEFRISPLNKFGFVETK	MYKKALIVATSILFLSACSSNTVKQHQIHTISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTDYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	67.77	gnl|BL_ORD_ID|391|hsp_num:0	418
NODE_6525_length_1718_cov_1.51112_3 # 1654 # 1716 # 1 # ID=6525_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.571	NODE_6525_length_1718_cov_1.51112_3 	1654	1716	+	Loose	1650	18.8606	Brucella suis mprF	60.0	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGCCGACGGCCGCACTCGCTTCCGTATGGCGTGGCCTTGATGCGATTTACCTCTTTAGTTCG	MPTAALASVWRGLDAIYLFSS	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	2.39	gnl|BL_ORD_ID|2130|hsp_num:0	2281
NODE_7048_length_1634_cov_1.30272_1 # 2 # 79 # 1 # ID=7048_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.269	NODE_7048_length_1634_cov_1.30272_1 	2	79	+	Loose	1000	22.7126	mecD	47.06	3004185	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam	antibiotic target replacement	methicillin resistant PBP2	ATTGCTGAAGTCCAAAATAAATTATCGGAATATGGAATCAATCTTGAAAAATTTAAGGTTGCTCAAAAAAATAACTGA	IAEVQNKLSEYGINLEKFKVAQKNN	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	3.69	gnl|BL_ORD_ID|2329|hsp_num:0	2828
NODE_7606_length_1558_cov_3.02595_1 # 2 # 163 # -1 # ID=7606_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.432	NODE_7606_length_1558_cov_3.02595_1 	2	163	-	Loose	2000	22.7126	Staphylococcus mupA conferring resistance to mupirocin	30.61	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic resistant isoleucyl-tRNA synthetase (ileS)	ATGCAATGGAATGGTGAGAAGGGGAGTGGAGTCGAATGGAACAGAGAGGAATGTAGAGGAGTGGAGAACATTGTAACGGAATGTAGTGGAATAGAATGGAATGAAATGGAATGGAGTGGAGTGAAGTGGAATGGAATTGAGTGGACTGCAATGGAATGTAAT	MQWNGEKGSGVEWNREECRGVENIVTECSGIEWNEMEWSGVKWNGIEWTAMECN	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	5.27	gnl|BL_ORD_ID|2146|hsp_num:0	2270
NODE_7683_length_1547_cov_1.9189_1 # 2 # 196 # 1 # ID=7683_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.544	NODE_7683_length_1547_cov_1.9189_1 	2	196	+	Strict	500	21.9422	mphC	100.0	3000319	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GATTACGTGCAGACGTTCTTAGCTGAAGCTGCGGCTGAATCTGAAGCACTCCAACGTCCCCTACCACAGGATGACGAAGGGCTCGAGCAGCTGATCCGTGACCTCTTCCAGAGTAGTGATCCCTACTTCACGCCCTCTGGCAAGCCAATCATCACGCGCCTCACGGAGCCAATGGTTGCCAACTTCTTCAACTAA	DYVQTFLAEAAAESEALQRPLPQDDEGLEQLIRDLFQSSDPYFTPSGKPIITRLTEPMVANFFN	MTQHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTKPEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKNFINTLAETLVDLHNIPEENITAHHINIKTIQEIKNDFQRRMNKVRETYGVADGLWNRWKQWLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDEGLEQLITAYDKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE	21.40	gnl|BL_ORD_ID|1972|hsp_num:0	2062
NODE_8050_length_1505_cov_1.46345_1 # 57 # 374 # -1 # ID=8050_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.390	NODE_8050_length_1505_cov_1.46345_1 	57	374	-	Loose	600	22.7126	cfrA	21.74	3003441	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGAATAAAAAAGAATTATTTGATGCTTTAGATGACTTTTCACAGCAATTGTTGGTAACCTTGGCAGACGTCGAAGCCATCAAAAAAAATCTCAAGAGTCTGGTAGAGGAAAATACAGCTCTTCGTTTAGAAAATGATAAACTGAGAGAACGATTGGGAGAAGTTGAGGAGACGGCTCCATCCAAAACTAAACATGTGAGGGAAAATGTTCGTCGCATTTATGAGGACGGTTTTCATGTTTGCCGTGACTTTTATGGCCAACGTCGAGAGCAAGATGCAGAATGTATGTTCTGTGATGAACTGTTGTTTAGGGAGTAA	MNKKELFDALDDFSQQLLVTLADVEAIKKNLKSLVEENTALRLENDKLRERLGEVEETAPSKTKHVRENVRRIYEDGFHVCRDFYGQRREQDAECMFCDELLFRE	MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQLYGNYQNSQ	30.09	gnl|BL_ORD_ID|657|hsp_num:0	696
NODE_8936_length_1419_cov_3.5044_2 # 1125 # 1418 # -1 # ID=8936_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.432	NODE_8936_length_1419_cov_3.5044_2 	1125	1418	-	Strict	1100	195.667	tetB(60)	97.94	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GAACGCCAACTCATTTCATTTGCCAGAGCGATTGTCTTTGACCCGAAAATCTTGATCTTAGATGAAGCGACTTCGCATATTGATACCGAGACGGAAGAGATTATTCAAAATGCGATTAATGTCGTTAAAGAAGGACGGACAACCTTTATGATTGCGCACCGACTTTCTACCATTGCTCATGCCGACCAAATTTTGGTGTTGGATAAAGGGGAAATTGTGGAACGCGGAACGCATGATGAATTGATGCAACTGCAAGGTCAATATGCCGAAATGGTGGCGCTCCAAAAAGGTTAA	ERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQILVLDKGEIVERGTHDELMQLQGQYAEMVALQKG	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	16.75	gnl|BL_ORD_ID|2252|hsp_num:0	2646
NODE_9171_length_1395_cov_1.95821_1 # 1 # 132 # -1 # ID=9171_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.364	NODE_9171_length_1395_cov_1.95821_1 	1	132	-	Strict	1300	20.0162	mdtO	100.0	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; acridine dye	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATGAAGGGTATATTGGGAGATAAAATGAATAATAATTTATTGCTATTACAATCAGACTTTTGTCTGGCAGATGATGCGGTATCGTCTATGATTGGAGTGCCCTTAGAAGAATCTCCAACCTTGCTCTTA	MMKGILGDKMNNNLLLLQSDFCLADDAVSSMIGVPLEESPTLLL	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	6.44	gnl|BL_ORD_ID|1966|hsp_num:0	2056
NODE_9499_length_1363_cov_3.29281_1 # 3 # 86 # -1 # ID=9499_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.345	NODE_9499_length_1363_cov_3.29281_1 	3	86	-	Loose	400	20.0162	vatA	58.33	3002840	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGAACGCGATTCAAGAATCATTTACGGATCAATTATTTGCCAACTATGAAGCAAATGTAAAATACCAAGCTATCGAAAATGCT	MNAIQESFTDQLFANYEANVKYQAIENA	MNLNNDHGPDPENILPIKGNRNLQFIKPTITNENILVGEYSYYDSKRGESFEDQVLYHYEVIGDKLIIGRFCSIGPGTTFIMNGANHRMDGSTYPFHLFRMGWEKYMPSLKDLPLKGDIEIGNDVWIGRDVTIMPGVKIGDGAIIAAEAVVTKNVAPYSIVGGNPLKFIRKRFSDGVIEEWLALQWWNLDMKIINENLPFIINGDIEMLKRKRKLLDDT	12.79	gnl|BL_ORD_ID|1657|hsp_num:0	1735
NODE_9568_length_1358_cov_2.15349_2 # 1271 # 1357 # 1 # ID=9568_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.552	NODE_9568_length_1358_cov_2.15349_2 	1271	1357	+	Loose	450	19.631	ANT(4')-Ib	40.91	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGGGTGACGATCGGAGTTTCGACGATGACATCCCCGAAAGGCACACAGACGTGAAATCGATACTACCTTCCTATGCCCCCGGTGCG	MGDDRSFDDDIPERHTDVKSILPSYAPGA	MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTEEAEFSHEWTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVEAQTFHDAICALIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAVKQSDLPSGYDHLCQFVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF	11.46	gnl|BL_ORD_ID|2189|hsp_num:0	2383
NODE_9799_length_1336_cov_1.27947_1 # 3 # 62 # -1 # ID=9799_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.600	NODE_9799_length_1336_cov_1.27947_1 	3	62	-	Loose	700	20.4014	emrD	58.33	3000309	protein homolog model	n/a	n/a		antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGATCGGCCAGACAAACGCCTGAAGACGCTGCTGCACCAGGAGAGCAACGCATTCGTG	MDRPDKRLKTLLHQESNAFV	MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPVDAPRTRLLTSYKTLFGNGGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV	5.05	gnl|BL_ORD_ID|1889|hsp_num:0	1974
NODE_10162_length_1305_cov_2.6568_1 # 1 # 87 # -1 # ID=10162_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.368	NODE_10162_length_1305_cov_2.6568_1 	1	87	-	Loose	1900	20.7866	MuxC	63.64	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGATAAAAAATGGGCAATGATTAGTGGTTTGGTAGGGTTTATTGGTGGTGGTTTTTCAGTCCTATCACCATTTCTGTTAACT	MKDKKWAMISGLVGFIGGGFSVLSPFLLT	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	2.80	gnl|BL_ORD_ID|2296|hsp_num:0	2720
NODE_11015_length_1236_cov_2.51312_1 # 3 # 422 # -1 # ID=11015_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.429	NODE_11015_length_1236_cov_2.51312_1 	3	422	-	Strict	770	281.567	patB	95.0	3000025	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGAAAATATGATTTTACAAGCCTGCCCAACCGTTTAGGGCACCATACCTATAAATGGAAAGAAGCAGAAACGGATAGTGAAATCCTACCAGCTTGGATAGCGGATATGGACTTTGTAGTCTTGCCTGAAATCCGCCAAGCTGTGCAAACTTACGCTGATCAACTGGTTTATGGCTATACCTATGCCAGTGAAGAGTTAATTAAGGAAGTCCAAAAGTGGGAAGCCACACAACACGGTTACCACTTTGACAAAGAGGCTCTTGTCTTTATCGAGGGTGTGGTCCCAGCTATCTCAACAGCTATTCAATCCTTTACAAAAGAAGGCGAAGCTGTTTTGATTAACACGCCTGTCTATCCACCTTTTGCTCGTAGTGTCAAGTTGAACAATCGTAGATTGATTACCAATTCTTTGGTGGAA	MGKYDFTSLPNRLGHHTYKWKEAETDSEILPAWIADMDFVVLPEIRQAVQTYADQLVYGYTYASEELIKEVQKWEATQHGYHFDKEALVFIEGVVPAISTAIQSFTKEGEAVLINTPVYPPFARSVKLNNRRLITNSLVE	MGKYDFTSLPNRLGHHTYKWKETETDSEVLPAWIADMDFVVLPEIHQAVQTYADQLVYGYTYASEDLIKEVQKWEATQYGYNFDKEALVFIEGVVPAISTAIQTFTKEGEAVLINTPVYPPFARSVKLNNRRLITNSLVEKDSLFEIDFDQLEKDLVEEEVKLYVLCNPHNPGGRVWEKEVLEKIGQLCQKHGVLLVSDEIHQDLTLFGHKHQSFNTINPAFKNFAIVLSSATKTFNIAGTKNSYAVIENPKLRLAFQKRLLANNQHEISGLGYLATEAAYRYGKDWLEELKQVFEDHINYVVDLFGKETKIKVMKPQGTYLIWLDFSAYDLTDETLQELLRNEAKVILNRGLDFGEEGSLHARINIAMPKSLLQEVCQRIVATFAKC	36.08	gnl|BL_ORD_ID|1984|hsp_num:0	2112
NODE_11223_length_1219_cov_1.67268_1 # 3 # 62 # -1 # ID=11223_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.467	NODE_11223_length_1219_cov_1.67268_1 	3	62	-	Strict	500	17.705	OXA-198	100.0	3001805	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTGTGTGGTGTATGGTGTGTGTGTCTGGTGTGTGTATGGTGTGTGTGTAGTGTGTGTA	MCVVYGVCVWCVYGVCVVCV	MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAKQRFSTASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCYQALARQVGAEKYRNYLRKSVYGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPFSASSYETLRQIMLIEQTPAFTLRAKTGWATRVKPQVGWYVGHVETPTDVWFFATNIEVRDEKDLPLRQKLTRKALQAKGIIE	7.63	gnl|BL_ORD_ID|716|hsp_num:0	758
NODE_12084_length_1162_cov_1.82475_1 # 49 # 1161 # -1 # ID=12084_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.531	NODE_12084_length_1162_cov_1.82475_1 	49	1161	-	Strict	1200	596.275	tetW	99.66	3000194	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGTTTTTGGAGCGGCAGCGTGGGATTACCATTCAAGCGGCAGTCACTTCCTTCCAGTGGCACAGATGTAAAGTTAACATTGTGGATACGCCCGGCCACATGGATTTTTTGGCGGAGGTGTACCGCTCTTTGGCTGTTTTAGATGGGGCCATCTTGGTGATCTCCGCTAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCTGCGGAAAATGAACATTCCCACCGTTATCTTTATCAACAAGATCGACCAGGCTGGCGTTGATTTGCAGAGCGTGGTTCAGTCTGTTCGGGATAAGCTCTCCGCCGATATTATCATCAAGCAGACGGTGTCGCTGTCCCCGGAAATAGTCCTGGAGGAAAATACCGACATAGAAGCATGGGATGCGGTCATCGAAAATAACGATGAATTATTGGAAAAGTATATCGCAGGAGAACCAATCAGCCGGGAAAAACTTGCGCGGGAGGAACAGCAGCGGGTTCAAGACGCCTCCCTGTTCCCAGTCTATCATGGCAGCGCCAAAAATGGCCTTGGCATTCAACCGTTGATGGATGCGGTGACAGGGCTGTTCCAACCGATTGGGGAACAGGGGGGCGCCGCCCTATGCGGCAGCGTTTTCAAGGTTGAGTACACCGATTGCGGCCAGCGGCGTGTCTATCTACGGTTATACAGCGGAACGCTGCGCCTGCGGGATACGGTGGCCCTGGCCGGGAGAGAAAAGCTGAAAATCACAGAGATGCGTATTCCATCCAAAGGGGAAATTGTTCGGACAGACACCGCTTATCAGGGTGAAATTGTTATCCTTCCCAGCGACAGTGTGAGGTTAAACGATGTATTAGGGGACCAAACCCGGCTCCCTCGTAAAAGGTGGNNNNNNNNNNCGAGGACCCCCTCCCCATGCTGCGGACGACGATTGCGCCGAAAACGGCAGCGCAAAGAGAACGGCTGCTGGACGCTCTTACGCAACTTGCGGATACTGACCCGCTTTTGCGTTGCGAAGTGGATTCCATCACCCATGAGATCATTCTTTCTTTTTTGGGCCGGGTGCAGTTGGAGGTTGTTTCCGCTTTGCTGTCGGAAAAATACAAGCTTGAAACAGTGGTAA	MFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWXXXXRTPSPCCGRRLRRKRQRKENGCWTLLRNLRILTRFCVAKWIPSPMRSFFLFWAGCSWRLFPLCCRKNTSLKQW	MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAVTSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQPIGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKGEIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIYMERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDGIRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM	57.90	gnl|BL_ORD_ID|364|hsp_num:0	389
NODE_12169_length_1157_cov_1.13702_1 # 1 # 231 # 1 # ID=12169_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.563	NODE_12169_length_1157_cov_1.13702_1 	1	231	+	Loose	2300	21.557	evgS	40.0	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GAATTAAGGAAAGTCGGCGCAACCGTCAAAGAAGAAGCCGAAGCCATACACATCACCCCGCCGGCACGACTCACGCCGAACGCCGTCATCGACACCTACGACGACCACCGCATGGCCATGTGCTTCTCACTGGTTGCACTGCTGGGCGTGCCCGTGACCATCAACGACCCGCAATGCACCCGCAAAACCTTCCCCGATTATTTCGCGGTATTTGAATCGTTGAAGGCTTAA	ELRKVGATVKEEAEAIHITPPARLTPNAVIDTYDDHRMAMCFSLVALLGVPVTINDPQCTRKTFPDYFAVFESLKA	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	6.35	gnl|BL_ORD_ID|1261|hsp_num:0	1318
NODE_12410_length_1142_cov_2.0828_2 # 938 # 1141 # -1 # ID=12410_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	NODE_12410_length_1142_cov_2.0828_2 	938	1141	-	Loose	550	23.8682	vgbC	36.11	3003990	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vgb lyase	ACCGACGATGACCTCGAGTACGTGCTGCGCGAGGCCTCCCGTGCCATGCGCGTACTCGCCGCCGGCGAGGCCGGGGCCCTGTGGATCGAAGACCCTTCGGACCCGCTGGCCCACCGCGTCACCATGCGCCACTCCGCGCTGCTGGTCACCGCCGACGAACTCGACGTCGCCGCGCGCGAGGCGGCGGTCGGCACGCTCGACTAA	TDDDLEYVLREASRAMRVLAAGEAGALWIEDPSDPLAHRVTMRHSALLVTADELDVAAREAAVGTLD	MQIAAQEYKTANRESGPYGITARQDRTIWFTEQKGNRIGRLTKDGDMRTFEVPTPDAGVMSILSAHTGDLWFTEYKANKIGRMTMEGTFAEFELPEANSSPYGLAEGPDGAIWFTELSGNRIGRITPAGIITEYDLPCEGSYPSYITAGPDGALWFTENQNNCIGRITVDGEITEYRIPTEQSGPVGITTGADGALWFVQINGNQIGRITTAGEITEFKLPSGNARPHAITAGVSGDLWFTEWGANQIGRITCTGDITEYPIPTPSAEPHGITVDSGGEVWFAEECDQIGRFTIQY	22.64	gnl|BL_ORD_ID|2240|hsp_num:0	2526
NODE_12924_length_1113_cov_2.23346_4 # 379 # 564 # -1 # ID=12924_4;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.500	NODE_12924_length_1113_cov_2.23346_4 	379	564	-	Loose	400	27.335	QnrB33	40.74	3002748	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGCTGAGATTTTGCCACTGCACCGCAGCCTGTGTGACAGAGGGAGATCCTGTCGAAACAAAGGAGTGGAATGGGATGCAGTGCAGTGGAGTGGAGTGGAATGGAGTGGAGTGGAGTGGAGTGGAGTGGAGTGGAAATGAATGGAGATTATTGGATTGGAATGGAGTGAAGTGTAATGGAATGTAG	VLRFCHCTAACVTEGDPVETKEWNGMQCSGVEWNGVEWSGVEWSGNEWRLLDWNGVKCNGM	MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG	28.50	gnl|BL_ORD_ID|1004|hsp_num:0	1048
NODE_13121_length_1104_cov_1.30696_1 # 1 # 225 # -1 # ID=13121_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.658	NODE_13121_length_1104_cov_1.30696_1 	1	225	-	Loose	700	23.8682	ACT-9	37.5	3001826	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGACAACACTGATCTGGCTTCGCGACGACCTCCGTCTAGCTGACCACCCGGCGCTGACAGCCGCCTGCTCAGCAGCAGATGGACCCGTGGTGGCACTGTGGATCCACGAAACCCGCAGGACCGATGAGGACAACAATCGGCACGGCCCACGCCCGCTCGGTGCAGCCACCCGGTGGTGGTACCACCGCAGCCTGCAACAGCTGGCACCGCGGCTTGCTGACCTT	MTTLIWLRDDLRLADHPALTAACSAADGPVVALWIHETRRTDEDNNRHGPRPLGAATRWWYHRSLQQLAPRLADL	MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVTANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNTSLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMNFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEAYGVKTNIQDMASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLLVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSAL	19.74	gnl|BL_ORD_ID|1108|hsp_num:0	1155
NODE_13309_length_1094_cov_26.795_2 # 18 # 755 # -1 # ID=13309_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	NODE_13309_length_1094_cov_26.795_2	18	755	-	Strict	400	491.115	ErmB	98.37	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAACACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCATGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCGTTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	98.79	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_13419_length_1088_cov_1.77832_3 # 975 # 1088 # 1 # ID=13419_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	NODE_13419_length_1088_cov_1.77832_3 	975	1088	+	Loose	275	20.0162	AAC(6')-IIb	38.1	3002595	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGTGAGCGTCGCTATTCCGACGGGTACCGTAAGCTGCGGCGGGCCGACGAACCCCGTCGCATCGCCTACGAGGTGCTTCACGAGGTGGCCACCCAGGGTGCCTTCGCGAAC	MSERRYSDGYRKLRRADEPRRIAYEVLHEVATQGAFAN	MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYIGLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA	21.11	gnl|BL_ORD_ID|126|hsp_num:0	140
NODE_14606_length_1029_cov_1.81314_1 # 2 # 127 # -1 # ID=14606_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.595	NODE_14606_length_1029_cov_1.81314_1 	2	127	-	Strict	1900	22.3274	MuxC	100.0	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACACAAGAAGGGTCTGGGTTCCTCCCGCAACGGCCGTGACTCGAACGCACAGTACCTGGGCGTTAAGCGCTACGGCGGCCAGTTTGTTAAGGCCGGAGAGATTATCGTGCGTCAGCGCGGC	MAHKKGLGSSRNGRDSNAQYLGVKRYGGQFVKAGEIIVRQRG	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	4.05	gnl|BL_ORD_ID|2296|hsp_num:0	2720
NODE_14640_length_1028_cov_13.7564_1 # 1 # 546 # 1 # ID=14640_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.381	NODE_14640_length_1028_cov_13.7564_1 	1	546	+	Strict	1200	377.867	tetM	98.34	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	CAGTATGAGAGCTCGGTTTCTCTTGGATACTTAAATCAATCGTTTCAAAATGCAGTTATGGAGGGGATACGCTATGGCTGTGAACAAGGATTGTATGGTTGGAATGTGACGGACTGTAAAATCTGTTTTAAGTATGGCTTATACTATAGCCCTGTTAGTACCCCAGCAGATTTTCGGATGCTTGCTCCTATTGTATTGGAACAAGTCTTAAAAAAAGCTGGAACAGAATTGTTAGAGCCATATCTTAGTTTTAAAATTTATGCGCCACAGGAATATCTTTCACGAGCATACAACGATGCTCCTAAATATTGTGCGAACATCGTAGACACTCAATTGAAAAATAATGAGGTCATTCTTAGTGGAGAAATCCCTGCTCGGTGTATTCAAGAATATCGTAGTGATTTAACTTTCTTTACAAATGGACGTAGTGTTTGTTTAACAGAGTTAAAAGGGTACCATGTTACTACCGGTGAACCTGTTTGCCAGCCCCGTCGTCCAAATAGTCGGATAGATAAAGTACGATATATGTTCAATAAAATAACTTAG	QYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT	MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAVTSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIEGNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGRSVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT	28.33	gnl|BL_ORD_ID|1618|hsp_num:0	1692
NODE_15390_length_993_cov_1.51066_3 # 911 # 991 # 1 # ID=15390_3;partial=01;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.605	NODE_15390_length_993_cov_1.51066_3 	911	991	+	Loose	500	20.0162	vanWB	66.67	3002964	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	GTGGTTGTCCAAGCTACCCAGGTAGCGCTTGGAGTAGGGGAACAGGCCGTGATCCATGTGGTGCTGGATGGTGGCGCGCTT	VVVQATQVALGVGEQAVIHVVLDGGAL	MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ	9.82	gnl|BL_ORD_ID|993|hsp_num:0	1036
NODE_16664_length_943_cov_2.36149_3 # 865 # 942 # 1 # ID=16664_3;partial=01;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.436	NODE_16664_length_943_cov_2.36149_3 	865	942	+	Loose	1650	21.1718	Brucella suis mprF	45.83	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGGAATGGAATGGAATGGTATGGAATAAAATTGAGTACAGTGGAGTGGACTGGAATGTGGTGAAGTGGAATGGAACG	VEWNGMVWNKIEYSGVDWNVVKWNGT	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	2.95	gnl|BL_ORD_ID|2130|hsp_num:0	2281
NODE_17469_length_913_cov_2.28555_1 # 2 # 181 # -1 # ID=17469_1;partial=10;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.400	NODE_17469_length_913_cov_2.28555_1 	2	181	-	Strict	600	21.1718	Burkholderia pseudomallei Omp38	100.0	3004123	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	ATGAACGCGATTCAAGAATCATTTACTGATAAATTATTTGCCAACTATGAAGCAAATGTCAAATACCAAGCGATTGAAAATGCTGCTAGCCACAACGGAATTTTTGCAGCCCTAGAACGTCGCCAAAGCCATGTAGACAATACACCTGTTTTCTCATTGGATTTGACCAAGGACAAGGTG	MNAIQESFTDKLFANYEANVKYQAIENAASHNGIFAALERRQSHVDNTPVFSLDLTKDKV	MNKTLIVAAVAASFATVAHAQSSVTLYGVLDAGITYQSNVATPSGSGKSLWSVGAGVDQSRFGLRGSEDLGGGLKAIFTLESGFNIGNGRFNNGGGMFNRQAFVGLSSNYGTVTLGRQYDATQDYLSPLSATGTWGGTYFAHPLNNDRLNTNGDVAVNNTVKFTSANYAGLQFGGTYSFSNNSQFANNRAYSAGASYQFQGLKVGAAYSQANNAGANTTGATDPLTGFNIGGTNAASIQGRSRVYGAGASYAYGPLQGGLLWTQSRLDNLANGAPTIRADNYEANVKYNLTPALGLGVAYTYTNAKANGESTHWNQVGVQADYALSKRTDVYAQAVYQRSSKNANASIYNGDLSTPFSTSINQTAATVGLRHRF	16.04	gnl|BL_ORD_ID|2317|hsp_num:0	2786
NODE_18301_length_885_cov_1.2494_3 # 739 # 885 # 1 # ID=18301_3;partial=01;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.272	NODE_18301_length_885_cov_1.2494_3 	739	885	+	Loose	850	21.9422	baeS	34.38	3000829	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGAGACAGTAAGATTTTTAATTGATTTTGTATTGCATATAGATAAACATCTAGGTGAACTTATGATTCAACATGGACCATGGTGGATGTATGGAATAATATTTTTAATAATATTTATAGAAACTGGTTTAGTTTTTATGCCATTC	LETVRFLIDFVLHIDKHLGELMIQHGPWWMYGIIFLIIFIETGLVFMPF	MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV	10.49	gnl|BL_ORD_ID|949|hsp_num:0	986
NODE_19430_length_851_cov_2.42839_1 # 3 # 143 # 1 # ID=19430_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.482	NODE_19430_length_851_cov_2.42839_1 	3	143	+	Loose	400	24.2534	QnrB48	26.19	3002763	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTAGACTGGATTGGAGTGGAGTGGAATGGAATGGAGTGGAGTAGAACGGAATGGAAGAGAACGGAATGGAACGGAATGGAATGGAGTGGAATAGAGTGGAGTGGATTTGATTGGAGTGGATCGGACTGCAGTGGAATGTAG	VDWIGVEWNGMEWSRTEWKRTEWNGMEWSGIEWSGFDWSGSDCSGM	MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG	21.50	gnl|BL_ORD_ID|904|hsp_num:0	946
NODE_19472_length_849_cov_1.3728_2 # 713 # 847 # -1 # ID=19472_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	NODE_19472_length_849_cov_1.3728_2 	713	847	-	Loose	920	22.7126	adeH	41.67	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GCCGCCGGGGTGCTGGCCACCCGGTCCCTGCGCTCGGGTTCCGTCCCCTACGACGTGCCCGAGCTCGACGCGGACCTGGCGGCCTACTTCCATCGTGGCCAGCGGGACCCGGACTCATCGACATTTTCTTCATAG	AAGVLATRSLRSGSVPYDVPELDADLAAYFHRGQRDPDSSTFSS	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	9.11	gnl|BL_ORD_ID|509|hsp_num:0	542
NODE_19659_length_844_cov_1.21546_2 # 307 # 843 # -1 # ID=19659_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.363	NODE_19659_length_844_cov_1.21546_2 	307	843	-	Strict	1320	361.688	lmrD	99.44	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ACTGATATTCGTGAATTTGATTTAGATAGCTTACGTTCCAATGTCGGAATTGTTTTGCAAGAGTCTGTTCTCTTTGATGGAACGATTGCTGATAATATCAAGTTTGGTAAACCAAATGCTACTCAAGAAGAAATTGAAACAGTGGCTAAGACAACTCACATTCATGATTTCATTGATAGCTTGCCTGACAAGTACGAAACACATGTTTCGGATGATGAATCAGTCTTCTCAGTTGGTCAAAAACAACAAATTTCTATCGCACGTACCATTTTGACAAATCCAGAACTTTTGATTTTGGATGAAGCAACTTCAAATGTGGATACAGTAACTGAACAACGAATTCAATGGGCGATGGAAGCTGCTATTGCTGGTCGTACTTCATTCGTTATTGCTCACCGTTTGAAAACAATTCTTAATGCAGATAAGATTGTTGTTCTTAAAGATGGTGAAGTTATCGAAGAAGGAAATCACCATGAACTCGTTGCTCAAGGTGGCTTCTACTCTGAACTTTATCACAATCAATTTGTTTTTGAATAA	TDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQRIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVFE	ENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVF	26.89	gnl|BL_ORD_ID|1550|hsp_num:0	1624
NODE_21200_length_798_cov_1.50875_1 # 3 # 107 # -1 # ID=21200_1;partial=10;start_type=ATG;rbs_motif=AATAA;rbs_spacer=4bp;gc_cont=0.286	NODE_21200_length_798_cov_1.50875_1 	3	107	-	Strict	400	20.0162	ErmT	100.0	3000595	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAATTAGATAAATTATTTGAACAATTCCTTTCTTTATTTAAGAAAGAAGATCCGACGATTCAAGAAACGGAAATCAATGATACTGAAATAGAAGAAAGTGAG	MKLDKLFEQFLSLFKKEDPTIQETEINDTEIEESE	MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFSFELAKRCNYVTAIEIDPKLCRITKNKLIEYENFQVINKDILQFKFPKNKSYKIFGNIPYNISTDIIRKIVFESTATESYLIVEYGFAKRLLNTNRSLALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHPSKISLKDRKQYENFVMKWVNKEYIKLFSKNQFYQALKYARIDDLNNISFEQFLSLFNSYKLFNR	14.34	gnl|BL_ORD_ID|1218|hsp_num:0	1275
NODE_21445_length_793_cov_3.87127_1 # 1 # 81 # 1 # ID=21445_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.494	NODE_21445_length_793_cov_3.87127_1 	1	81	+	Loose	1150	19.2458	blaR1	42.86	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	blaZ beta-lactamase	TGTGTAGTGGAGTGGAGAGGTGTGGAATGGAGTGGAGTGGAGTTGAATTCAATGGGATGGCATGAAAGGGAGTGGAAGTGA	CVVEWRGVEWSGVELNSMGWHEREWK	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	4.42	gnl|BL_ORD_ID|1973|hsp_num:0	2063
NODE_21875_length_781_cov_1.38705_2 # 602 # 781 # -1 # ID=21875_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.439	NODE_21875_length_781_cov_1.38705_2 	602	781	-	Loose	1300	22.3274	vanTG	52.94	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	TATAATAATATATATATCATTAGACTTGGAGTTAAGCAGATGATTCTCCATAATATTGAGTGGGCCCCATCCAATCAGTTGAAGGCCTTAAGACTGAGGTCCCCTGAGAAGGATGAGATCCTGCTAGAGATGGACTTGAGACCCGCACTGTGGCATTTACCGGGCCACTTGGCAGGGTAA	YNNIYIIRLGVKQMILHNIEWAPSNQLKALRLRSPEKDEILLEMDLRPALWHLPGHLAG	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	8.29	gnl|BL_ORD_ID|1488|hsp_num:0	1561
NODE_23179_length_748_cov_4.19192_3 # 642 # 746 # -1 # ID=23179_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.514	NODE_23179_length_748_cov_4.19192_3 	642	746	-	Loose	400	20.0162	catD	53.85	3002682	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GGCGAAACTGAAACCCGTAAAACCGCCAAAATACGCGGCGGCGAAGTGATTGAATTTGACGGCGCACGCTTGGAAATTGCCGATGGATACGACCCTGAAGAATAA	GETETRKTAKIRGGEVIEFDGARLEIADGYDPEE	MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNRHSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYGNNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPLAIQVHHAVCDGFHICRFVNELQELINS	16.43	gnl|BL_ORD_ID|1496|hsp_num:0	1569
NODE_23339_length_744_cov_1.29898_2 # 429 # 743 # -1 # ID=23339_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.673	NODE_23339_length_744_cov_1.29898_2 	429	743	-	Loose	500	26.1794	CTX-M-41	28.3	3001903	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	GACGGCGGCAGCGGGTTCGCGTCCGCAGTGGCCGAGGAGTGGCCGGAGACCAGGGTCCAGAGGTGCCTGTTCCACGCGTTCTGCCAGGTCAAGCGCTGCACGACGACCAGGCCGAAGCTGCAGGCGGGGAGGGAGCTCTACGGGCTGGCGAAGGAGCTTATGCGCATAGAGGACCTGCGCCAGGCCGAGTGGTGGGTGAAGCGCTACATGCAGTGGAACGAGTTCTGGTGCGACTTCCTGGAGGACAGGACCATGGNNNNNNNNNNCGTTGGGAGTACACGCACGAGAGGCTCAGGAAGGCCAGGCGCGGCCTGA	DGGSGFASAVAEEWPETRVQRCLFHAFCQVKRCTTTRPKLQAGRELYGLAKELMRIEDLRQAEWWVKRYMQWNEFWCDFLEDRTMXXXXVGSTRTRGSGRPGAA	MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQTLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTMTFGELIAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGSGGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY	35.74	gnl|BL_ORD_ID|534|hsp_num:0	567
NODE_23807_length_734_cov_1.14728_1 # 1 # 126 # -1 # ID=23807_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.333	NODE_23807_length_734_cov_1.14728_1 	1	126	-	Loose	700	20.4014	ADC-22	57.14	3003866	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	ATGGAAAATCCTTGGATAGATACTACTTCGGAAATATATAATGGTGAGAAGATAATCGTTGCTACTGCGGACCTGAAGTATATTAAAAAGCTATTAAATTCAAAAAAATATCCCCCAGTAGATAAA	MENPWIDTTSEIYNGEKIIVATADLKYIKKLLNSKKYPPVDK	MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	10.97	gnl|BL_ORD_ID|2293|hsp_num:0	2352
NODE_24382_length_721_cov_1.81532_1 # 3 # 362 # 1 # ID=24382_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.483	NODE_24382_length_721_cov_1.81532_1 	3	362	+	Strict	400	238.81	pgpB	100.0	3003920	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	lipid A phosphatase	TACATATCGCTGGCATTATTTACGAGCCGTATTTTTCGGAATAAATTCTACACGTGGACGATCTGGAGCGTCGTCGCACTCGTCATCTATAGCCGTATTTATATCGGAGTGCATTTCATCACCGATATTATCCCGGGTATCGCCGTCGGACTTATCGTAGGACACTTTGTTTATAAAGTCTATCTGTATGCACGTTCCCGTTGGTTGGGAGCCTCATGCCCTGCCCATCCGTCGGCAGTCTATGCCGGCGATTCCATTCGGCTTTGGACACTTAGCCTCATCGGCTTTGTCTTTGCCATGCTGTGTATGTCCCGCCAGTTGACAGAGATACTACAGTACTATGTCTTCCTGCTCTTCTGA	YISLALFTSRIFRNKFYTWTIWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYKVYLYARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGFVFAMLCMSRQLTEILQYYVFLLF	MEYILEVERNLFLTLNGVQHPLLDGFFYLISAKWTWVIMSIAFLFFLFYKKPTKEALFIVGAVLLSVLICDQLSSSFFKPFFARFRPSHHPDFIDYVKTVYGYRGGKYGFISGHTTNYISLALFTSRIFRNKFYTWTIWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYKVYLYARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGFVFAMLCMSRQLTEILQYYVFLLF	50.42	gnl|BL_ORD_ID|2209|hsp_num:0	2397
NODE_24704_length_715_cov_1.51667_1 # 1 # 714 # -1 # ID=24704_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.370	NODE_24704_length_715_cov_1.51667_1 	1	714	-	Strict	1050	484.182	lmrC	99.16	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	AAACGAATTATTACCGTAATGTCATCAACAACTTATAGCCGTCATCAAATGGCTGACAAGGTTTCAGGATATGGAGTTGAGCTTTTAATTGTTGCTGGGATAGGAATAATTTTTGCCATCTTTAGTACACTTTCAGCCGCACGAATTGCCCAAGAAATTGGAGCAGACGTTCGTGAAGCGACTTACAAAAAAATCAATACATTTTCTTATGAAAATGTTGAAAAGTTCAATGCAGGAAACCTTGTTGTTCGGATGACAAATGACGTCACACAAGTTCAAAACTTGATGATGATGGTTTTCCAAATTTTGATGCGGATTCCAGTCCTTTTGATTGGTGCGGTTGTTCTTTCTATCACAACTCTTCCAAGATTATGGTGGATTACAGTTCTTTTAATTGTTTTAATCGTATTAGTCACAGCCGTTTTAATGGGACGCATGGGTCCTCACTTTATGGCTTTCCAAAAATTGATGGACCGTATTAATGCCATTGCTAAACAAAACTTGCGTGGTTCACGTGTCGTTAAATCATTCGTTCAAGAAAAAAATCAAATTAAAGATTTTGATGAAACTTCTGATGAACTTTACGATCATAACTGGGCAGTAGGAAAACTCTTCTCAGCAATGATTCCACTCTTTACTGTAATTGCTCAAGGAGCAATTTGGCTTGCTATTTACTTTGTTTCAACTTTTGTAACAGAGTCAACAACAGTTGCC	KRIITVMSSTTYSRHQMADKVSGYGVELLIVAGIGIIFAIFSTLSAARIAQEIGADVREATYKKINTFSYENVEKFNAGNLVVRMTNDVTQVQNLMMMVFQILMRIPVLLIGAVVLSITTLPRLWWITVLLIVLIVLVTAVLMGRMGPHFMAFQKLMDRINAIAKQNLRGSRVVKSFVQEKNQIKDFDETSDELYDHNWAVGKLFSAMIPLFTVIAQGAIWLAIYFVSTFVTESTTVA	KHKWVALFSIVSTFIYAGVQLYQPQIMKRIMTVMSSTTYSRHQMADKVSGYGVELLVVAGIGIIFAIFSTLSAARIAQEIGADVREATYKKINTFSYENVEKFNAGNLVVRMTNDVTQVQNLMMMVFQILMRIPVLLIGAVVLSITTLPRLWWITVLLIVLIVLVTAVLMGRMGPHFMAFQKLMDRINAIAKQNLRGSRVVKSFVQEKNQIKDFDETSDELYDHNWAVGKLFSAMIPLFTVIAQGAIWLAIYFVSTFVTESTTVAQDSIGGIATFMTYMGMIMFAIIMGGMISMFASRGMVSIGRINEVLNTDPAMKFDENAKDEVLSGSVKFDHVSFSYPNDEEPTLKDISFEVEPGQMVGIVGATGAGKSTLAQLIPRLFDPTEGTVSVGGKDLKTVSRGTLKKNISIVLQKAILFSGTIAGNIKQGKADATDEEMTRAARIAQAAEFITTKDGQYDSEVEERGNNFSGGQKQRLSITRGVVKNPNVLILDDSTSALDAKSEKLVQEALNKDLKDTTTIIIAQKISSVVHADNILVLDQGKLVGQGTHQELVAENKIYQEIYDTQKAQED	41.61	gnl|BL_ORD_ID|938|hsp_num:0	974
NODE_25496_length_698_cov_2.24417_2 # 131 # 448 # -1 # ID=25496_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.371	NODE_25496_length_698_cov_2.24417_2 	131	448	-	Strict	350	22.7126	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAACAAGAAAGAATTATTTGATGCTTTAGATGATTTTTCTCAACAATTATTGGCAACCTTGGCAGATGTTGAAGCCATCAAAAAGAATCTCAAGAGTGTCATTGAAGAGAATACAGCTCTTCGTTTAGAAAATGATAAACTAAGAGAGCGCTTGAGTGAGGAAGAAGAAACTGCTCCAACTAAGACCAAACATGTTAGAGAAAATGTGAGCCGAATCTATGACGACGGTTTTCATGTATGTCGTGATTTTTATGGCCAGCGTCGTGAAAAAGATGCAGAATGTATGTTTTGCGATGAATTGTTGTTTAGGGAGTAA	MNKKELFDALDDFSQQLLATLADVEAIKKNLKSVIEENTALRLENDKLRERLSEEEETAPTKTKHVRENVSRIYDDGFHVCRDFYGQRREKDAECMFCDELLFRE	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	50.72	gnl|BL_ORD_ID|790|hsp_num:0	823
NODE_26281_length_681_cov_1.44569_2 # 208 # 681 # -1 # ID=26281_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.620	NODE_26281_length_681_cov_1.44569_2 	208	681	-	Strict	500	306.22	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic; sulfone antibiotic	antibiotic target replacement	sulfonamide resistant sul	TATCCGCAATTGGCGAAATCATCTGCCAAACTCGTCGTTATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAACGCAACCGCCTTGTCCTTGATCCCGGCATGGGGTTTTTTCTGGGGGCTGCTCCCGAAACCTCGCTCTCGGTGCTGGCGCGGTTCGATGAATTGCGGCTGCGCTTCGATTTGCCGGTGCTTCTGTCTGTTTCGCGCAAATCCTTTCTGCGCGCGCTCACAGGCCGTGGTCCGGGGGATGTCGGGGCCGCGACACTCGCTGCAGAGCTTGCCGCCGCCGCAGGTGGAGCTGACTTCATCCGCACACACGAGCCGCGCCCCTTGCGCGACGGGCTGGCGGTATTGGCGGCGCTGAAAGAAACCGCAAGAATTCGTTAA	YPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	57.93	gnl|BL_ORD_ID|910|hsp_num:0	952
NODE_26307_length_681_cov_1.28594_1 # 2 # 118 # -1 # ID=26307_1;partial=10;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.231	NODE_26307_length_681_cov_1.28594_1 	2	118	-	Loose	500	20.7866	CTX-M-67	39.29	3001928	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAGTTTATTACATGAATCAATTGAAAGTTTAGAACTTAAACTTAAAAATAAAGAAATTAAACCAAGTGATTTAGTAAAAGAATCACTAGACAGAATTAAAGCTACTGATGAAAAA	MSLLHESIESLELKLKNKEIKPSDLVKESLDRIKATDEK	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYSPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	13.40	gnl|BL_ORD_ID|1216|hsp_num:0	1272
NODE_26626_length_675_cov_1.4629_2 # 491 # 673 # -1 # ID=26626_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.322	NODE_26626_length_675_cov_1.4629_2 	491	673	-	Loose	2030	21.1718	ceoB	28.21	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	AATAACTCCATATATAAAAAGGTTGGTGATTATTACTATCTAGCGACAGATACATATGTAACGGATGGTAATTTTAAATCTTGCCTACCAGATGGCTCTGAATATAAAAAAGAACAGGATAAAGCTAAGGATATTGCCAGCTATGCTAAAAAAATTGTTCAAAATTTAGAACAGTCCCAGTAG	NNSIYKKVGDYYYLATDTYVTDGNFKSCLPDGSEYKKEQDKAKDIASYAKKIVQNLEQSQ	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	5.84	gnl|BL_ORD_ID|1196|hsp_num:0	1252
NODE_27513_length_658_cov_1.2869_2 # 451 # 657 # -1 # ID=27512_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.353	NODE_27513_length_658_cov_1.2869_2 	451	657	-	Loose	550	21.9422	NmcR	42.86	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	AATCTACACGATAAAAGTGAGGGAGCCCTTTATAAAAATATCATAGGCACATATCTCCACGGCTCTCTATTACCCAAAAACCCTAGAATTACAGATTTCTTGATTCAGCAAGCAGCAATTAATAGATATGGTAAATTTATTCCAGCTGAAATAAATGATGGTTTAATTGAAAAAGCGCGTGTATCTGCTATGAGTCGTCCACGTTAA	NLHDKSEGALYKNIIGTYLHGSLLPKNPRITDFLIQQAAINRYGKFIPAEINDGLIEKARVSAMSRPR	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	23.05	gnl|BL_ORD_ID|1978|hsp_num:0	2072
NODE_29256_length_631_cov_1.23611_1 # 2 # 367 # 1 # ID=29249_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.317	NODE_29256_length_631_cov_1.23611_1 	2	367	+	Loose	550	24.2534	SHV-143	36.96	3001344	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATTAATAACCAAAAAATGTCATATCTATATTCTACAGGAGATGCATATGTATTCATGGACAATGCTACTTATGAACAAATCGAAGTTCCTGAAGCACAATTAGAACATGAATTAAACTTCTTAAAAGAGAATATGGAAGTATCTATTTTAATGTTTGGTGATGAAATTTTAGGTATTGATTTACCTACAACTGTAGAATTAGAAGTTACTGAAACTGAACCTGGAGTAAAAGGTGATACTGCTCAAGGTGCTACAAAAGCAGCTACAGTTGAAACAGGTTATACTCTACAAGTCCCTCTATTTGTTAAAGAAGGTGATGTATTAGTTATTAATACATCTGAAGGTACATATGTATCTAGAGCATAG	INNQKMSYLYSTGDAYVFMDNATYEQIEVPEAQLEHELNFLKENMEVSILMFGDEILGIDLPTTVELEVTETEPGVKGDTAQGATKAATVETGYTLQVPLFVKEGDVLVINTSEGTYVSRA	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDLWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	42.31	gnl|BL_ORD_ID|1462|hsp_num:0	1533
NODE_30627_length_611_cov_1.31115_1 # 2 # 610 # 1 # ID=30609_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.417	NODE_30627_length_611_cov_1.31115_1 	2	610	+	Strict	750	393.66	pmrA	98.52	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GCTGGGCTTGCCATGACCATTACTATGGGAGGCTTAGCCTTTGTACCAAATATCTATTGGTTAATCTTTCTTCGCTTACTAAACGGTGTATTTGCGGGTTTTGTTCCCAATGCAACTGCCTTGATAGCCAGTCAGGTTCCCAAGGAGAAATCAGGCTCTGCCTTAGGTACTTTGTCTACAGGCGTAGTTGCAGGTACTCTAACTGGTCCTTTTATTGGTGGCTTTATCGCAGAATTATTTGGCATTCGTACTGTCTTTTTACTGGTTGGTAGTTTTCTATTTTTAGCTGCTGTTTTGACTATTTGCTTTATCAAGGAAGATTTTCAACCAGTAGCCAAGGAAAAGGTCATCCCAACCAAGGAATTATTTACATCAGTTAAATATCCCTATCTTTTGGTCAACCTCTTTCTGACTAGTTTTGTCATCCAATTTTCAGCCCAATCAATCGGCCCTATCTTAGCTCTGTATGTACGCGACTTAGGCCAGACAGAGAATCTTCTCTTTGTATCAGGTTTGATTGTATCCAGTATGGGCTTTTCCAGTATGATGAGTGCAGGAGTCATGGGCAAGCTAGGTGATAAAGTGGGTAATCATCGCCTCTTAGTTGTA	AGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAVLTICFIKEDFQPVAKEKVIPTKELFTSVKYPYLLVNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVV	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	50.88	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_32134_length_591_cov_1.47201_2 # 391 # 591 # -1 # ID=32094_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.507	NODE_32134_length_591_cov_1.47201_2 	391	591	-	Loose	300	22.3274	lnuD	32.5	3002838	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	CTTCCGGAAAATGCTTTCGGTGAATTGGGGGACGAGGTAGATACGCTAAGTGGGCTCTTCTTGGAAATCAAGCAGGAACTCCCCCATGTGGGCGATACAGCAGTGTACGAGCCATTCCGCTTTCAAGTGACCCAAATGGACAAGCGCCGAATCATCGAAATCAAGATTTTCCCTTTCGAGCGCACTTGGGAGGTCGAATAG	LPENAFGELGDEVDTLSGLFLEIKQELPHVGDTAVYEPFRFQVTQMDKRRIIEIKIFPFERTWEVE	MVNKADAIEIILYAEENEIDIWLDGGWGVDALLGEETRSHNDIDLFVEEKNGKTFIEILKEKGFTEVIEAYTTTDHTVWKDDKDRIIDLHVFEFNEQGDLVFEGESYPSNVFSGIGKIGNKVVKCIDAENQVLFHLGYEHDENDVHDVRLLCERYNIPVPSEYK	40.24	gnl|BL_ORD_ID|1849|hsp_num:0	1934
NODE_32580_length_586_cov_1.86064_2 # 237 # 554 # -1 # ID=32529_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.406	NODE_32580_length_586_cov_1.86064_2 	237	554	-	Strict	350	22.7126	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAACAAGAAAGAATTATTTGATGCCTTAGATGATTTTTCTCAACAGTTGTTGGCAACCTTGGCAGATGTCGAAGCCATCAAAAAAAATCTCAAGAGTGTTGTAGAAGAGAATACAGCTCTTCGTTTAGAGAACGATAAACTGAGAGAGCGCTTGAGTGAGGAAGAAGAAACAGCTCCAACGAAGACCAAGCATGTCAGAGAAAACGTGAGCCGAATCTATGACGACGGTTTTCATGTGTGTCGCGACTTTTATGGCCAACGTCGTGAACAAGATGCAGAATGTATGTTTTGTGATGAATTGTTGTTTAGGGAGTAA	MNKKELFDALDDFSQQLLATLADVEAIKKNLKSVVEENTALRLENDKLRERLSEEEETAPTKTKHVRENVSRIYDDGFHVCRDFYGQRREQDAECMFCDELLFRE	MQFTKIDINNWTRKEYFDHYFGNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTVFHKETETFSSIWTEFTADYTEFLQNYQKDIDAFGERMGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEEGGKYYIPLSIQVHHAVCDGFHVCRFLDELQDLLNK	50.72	gnl|BL_ORD_ID|790|hsp_num:0	823
NODE_32751_length_584_cov_2.21928_2 # 427 # 582 # 1 # ID=32699_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.622	NODE_32751_length_584_cov_2.21928_2 	427	582	+	Loose	700	21.9422	ADC-8	39.29	3003854	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	ATGGCAACAGTAGACCGCAACGGCATCCCCTTAGTAAATGGCGTCCTCTACGGCTGGGCTGAGGTCCTTGTCGCCATCGCTGGCGTGCCCCTCACGGGCATCACCTCGGTCGAGTACGCCGACAAGCAGGAGGTGACGAACAAGTACGGCGCAGGG	MATVDRNGIPLVNGVLYGWAEVLVAIAGVPLTGITSVEYADKQEVTNKYGAG	MMKDILGNLDNVPFKIMTGCIAGLLSCGTVAQSTVQQSIQQSVDRHFKPLMAQYQISGMAIAVSINGQHYYQNYGVASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHPAQYFPELKNTAVNQATLLNLGTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIREYSNPSIGLMGYVTALAMKNSYSNLIENTLFPALGMHHSYINVPAAQMSNYAWGYQADQAIRVSPGMFDAEAYGIKSNTADMLKFLDAQINPQNLKPTLRKAIQTTQMGYFRVGQMRQGLGWEQYTYPVSLTTLLAGNSAKMALQPQPVTGISKPITAPQQALLNKTGATNGFSAYVVVIPSQKIGLVMLANRNFPNDARVKAAYATLQQILNADIQK	13.10	gnl|BL_ORD_ID|2185|hsp_num:0	2341
NODE_33251_length_578_cov_0.912046_1 # 3 # 212 # 1 # ID=33190_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	NODE_33251_length_578_cov_0.912046_1 	3	212	+	Loose	1200	25.409	TaeA	45.16	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	CTGTGCACCCGGTTCGGTGGCGGCCCGGTGGGGCTGACGACGCTGGCGGTCAGCGTGGGGGAGGAGCCTGAGACGGTGGAGACCGTGGCCGAGCCCTACCTGGTGCGTGAAGGACTGGTCGTACGCACCCCGCGGGGACGGGCGGCCACGCCGGCGGCCTACATCCACCTGGGACTTGAGCCCCCTGCGGACGGGGCATTGTTCTCCTGA	LCTRFGGGPVGLTTLAVSVGEEPETVETVAEPYLVREGLVVRTPRGRAATPAAYIHLGLEPPADGALFS	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	10.65	gnl|BL_ORD_ID|2236|hsp_num:0	2522
NODE_33303_length_577_cov_1.02874_1 # 490 # 576 # -1 # ID=33242_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.391	NODE_33303_length_577_cov_1.02874_1 	490	576	-	Loose	890	20.4014	OprA	58.33	3003039	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGCTGGTTTATACGTTCGAGCCTGGTCAATCTTTGCCAATCAAAAAAGAAGTATTGTCGGTTGAGATTGAAGCCGTGAATGCTTAA	LLVYTFEPGQSLPIKKEVLSVEIEAVNA	MPLSKLSASSLALCLGLLGACSLAPRYQRPEAPIPTTYPAVPASQQAGDRARLDDWQQQFTDPVLRQMIGQALEHNRNLRVAALRIEEARALYGVQASERLPTLEASGRYERERMRGETREAGEVEQRYRVAAGISAFELDFFGRVKNLGDAALADYLASEEAQRSARIALIAEVAGGYVQERALYAQQRLAERTLHARENGLALVRKRYAAGMSTRIDLRSEEMLVESARATHAALVRERSQAVSGLQLLLGDFTGDWQDSQLDLEHLQLQPLPAGLPSELLARRPDIRQAEQQLRAANANIGAARAAFFPSLRLSTDLGSASSGLHGLFRGGSRVWTFSPQMTLPIFDGGRNRANLDLAEVRKDIAVNRYEESIQVAFREVADALSAGDQLELQLRAQRAVRDADRERLQLVRKRYAKGVANYLEMLDAQRSLFDSEQQLIHLRGLRLNNGVALYRALGGGWSQG	6.00	gnl|BL_ORD_ID|1497|hsp_num:0	1570
NODE_33400_length_576_cov_0.888676_1 # 343 # 576 # 1 # ID=33337_1;partial=01;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.761	NODE_33400_length_576_cov_0.888676_1 	343	576	+	Loose	1080	23.0978	rosB	60.0	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTGCTGGTTCACGTGGCCGGGACGGCCGACCTGGGGATCCCGCTGGCCATTGACGGGCGCAGTCGTCCGCGGCAGGAGACGGCGGAGCTCACGGAGAGCCGCCTGGGCGAGCTCGATGCCTGCCGGACCGGCGAGGAGGCCGCCGACCTGCTCCTCGACCTGCGCTTCCGGTCGGCCGATCACCGCGCCGACGGCGCGGAGCCGGGCACCTCGCCCGGCAGCGCCCTGCGC	MLLVHVAGTADLGIPLAIDGRSRPRQETAELTESRLGELDACRTGEEAADLLLDLRFRSADHRADGAEPGTSPGSALR	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	13.85	gnl|BL_ORD_ID|480|hsp_num:0	507
NODE_33542_length_575_cov_1.74808_1 # 1 # 165 # 1 # ID=33476_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	NODE_33542_length_575_cov_1.74808_1 	1	165	+	Strict	275	20.7866	AAC(6')-Iaa	100.0	3002571	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	AATCCCTGGTCACAGGGCGCGGCCACGATGAGCGACATCGGCGAGGGCGAGTGGCAGAGCTTCGTGTGCGTGGAGACCGCGGCGGTGCGCGAGCGGGCGCTGACGCTGTGGCCGGGGCACCCCCACATCATGACGCAGACCCTTGCCGTGGAGACGCTGGACTAA	NPWSQGAATMSDIGEGEWQSFVCVETAAVRERALTLWPGHPHIMTQTLAVETLD	MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQALGFEETERVIFYRKRC	37.24	gnl|BL_ORD_ID|1455|hsp_num:0	1526
NODE_36011_length_549_cov_1.21862_2 # 426 # 548 # 1 # ID=35846_2;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=15bp;gc_cont=0.325	NODE_36011_length_549_cov_1.21862_2 	426	548	+	Loose	700	21.1718	vanTrL	50.0	3002974	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAAAATAGTACTTGACCTCGATGGAACAATTTGTTCTTTGAGAAAAGAATGACAGGATTATGTTGATGTTGTTCCAAACTTTCAGGCTGTAGAAAAAATTCAAAAACTTAAGAAACAAGGG	MKIVLDLDGTICSLRKE*QDYVDVVPNFQAVEKIQKLKKQG	MVENKMRAYKEFYVESLLHNVQVIKKNIPKSTKIMAVVKANAYGINAVNVAIILEYIGIDFFAVATIDEAIALRKNGITSNILILGYTTPTKVDDLIHYELTQTIVSKEHAYFLNKTGKKIMCHLKVDTGMHRLGVEPTLEEICPIFNYPFLKIKGVYSHLGSADDLSEEGKQRTIKQISRYNTIIAELKRKRVDVGLTHLQSSYGILNYSELAYDYVRPGIILYGLLSNNDHNVKLHLDLQPVVAVKAQLISKKKIAPGEYIGYGTDTQLTSSKTIGVLSIGYADGIPRNLSNGEYCVVFEDKQIPQIGRICMDMMLVDLSNCSDIPLGVMVDVLPNIEEISQIQSTITNEIISCLGSRLGMEVK	11.20	gnl|BL_ORD_ID|1440|hsp_num:0	1510
NODE_36325_length_546_cov_0.816701_2 # 354 # 545 # -1 # ID=36135_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.620	NODE_36325_length_546_cov_0.816701_2 	354	545	-	Loose	680	21.1718	LpeA	27.78	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GGTACCGTCAGCGGACTGACCCCGGGTGCGGCTCAGGATTTGCTTCTCGTTTCCACGGATCGTGGCACTGTCATGGTTCCTTTCGTGACGGCGCTCGTTCCCACGGTTGACGTTGAGGGAGGGGTCGTTGTTATCGATGCGCCTCCCGGCTTGTTTGACGACGATGCGGTGTCGGAGCGCGAGGGCGACTGA	GTVSGLTPGAAQDLLLVSTDRGTVMVPFVTALVPTVDVEGGVVVIDAPPGLFDDDAVSEREGD	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	17.75	gnl|BL_ORD_ID|2307|hsp_num:0	2758
NODE_36387_length_546_cov_1.00611_1 # 2 # 544 # 1 # ID=36189_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.346	NODE_36387_length_546_cov_1.00611_1 	2	544	+	Strict	600	350.517	CfxA3	100.0	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	TACATCGAACTCACGTTAAATAATATAAACATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACA	YIELTLNNINMEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIAT	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	56.39	gnl|BL_ORD_ID|1813|hsp_num:0	1895
NODE_38038_length_531_cov_1.64076_1 # 94 # 531 # -1 # ID=37706_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.454	NODE_38038_length_531_cov_1.64076_1 	94	531	-	Strict	750	288.886	pmrA	99.31	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATTGTATCCAGTATGGGCTTTTCCAGTATGATGAGTGCAGGAGTCATGGGCAAGTTAGGTGACAAGGTGGGGAACCATCGCCTCTTGGTTGTAGCCCAGTTTTATTCAGTCATCATCTATCTCCTCTGTGCTAATGCCTCTAGCCCCCTTCAACTAGGACTCTATCGTTTCCTCTTTGGCTTGGGAACCGGTGCCTTGATTCCTGGAGTTAATGCCCTTCTCAGTAAGATGACTCCCAAAGCCGGCATTTCGAGGGTCTTTGCCTTTAACCAGGTATTCTTTTATCTGGGAGGTGTCGTTGGTCCCATGGCAGGTTCTGCAGTAGCAGGTCAATTTGGCTACCATGCAGTCTTTTATGCGACAAGCCTTTGTGTTGCCTTTAGTTGTCTCTTTAACCTTCTTCAATTTCGAACATTATTAAAAGTAAAGGAAATCTAG	IVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLLQFRTLLKVKEI	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	36.34	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_38563_length_526_cov_1.24416_2 # 410 # 526 # 1 # ID=38173_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.342	NODE_38563_length_526_cov_1.24416_2 	410	526	+	Loose	890	25.7942	cpxA	36.36	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATTGAATGGTGGAGGAGAATAGTTAAAGTTACAGAAAAATTTGATCCAATTTATTGTCTAACCGGTGAAATTGATTTGCGGGTTCATACTCAGTCTAGGACTATAATGGGAAAA	MIEWWRRIVKVTEKFDPIYCLTGEIDLRVHTQSRTIMGK	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	8.53	gnl|BL_ORD_ID|137|hsp_num:0	152
NODE_38604_length_526_cov_1.70064_1 # 3 # 158 # 1 # ID=38211_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.308	NODE_38604_length_526_cov_1.70064_1 	3	158	+	Loose	275	22.7126	AAC(6')-34	33.33	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GGATGTTTTAAAGTCTTAAAACCTAAAACCATAAAAACCCTGGAATATAACCTAGAAAATAACATTTGGGACATAGGTCTAGGCACGGATTTCATGATGAAAATGCCAAAAGCAATTGCAACAAAAACAAAAATGACAAATATAAGACCTAATTAA	GCFKVLKPKTIKTLEYNLENNIWDIGLGTDFMMKMPKAIATKTKMTNIRPN	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	25.89	gnl|BL_ORD_ID|2239|hsp_num:0	2525
NODE_38849_length_524_cov_0.991471_2 # 418 # 522 # 1 # ID=38428_2;partial=01;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=13bp;gc_cont=0.362	NODE_38849_length_524_cov_0.991471_2 	418	522	+	Loose	400	20.4014	kdpE	72.73	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGAATCAACTTGAACAAAAACTTGAGCAGGATTTTGGTATTGTTTTTAGCCAAAAAGACCTCTTAGAAACAGCATTTACCCATACCTCATATGCCAATGAGCAC	MNQLEQKLEQDFGIVFSQKDLLETAFTHTSYANEH	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	15.56	gnl|BL_ORD_ID|2171|hsp_num:0	2331
NODE_40655_length_509_cov_1.85903_1 # 449 # 508 # 1 # ID=40007_1;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.600	NODE_40655_length_509_cov_1.85903_1 	449	508	+	Strict	700	18.4754	vanSO	100.0	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGTTTCAGTTCCCTGCGTTAGCTCCCACGCTCAGCGTGGGTGACCGTCCTTCAGACGGC	MFQFPALAPTLSVGDRPSDG	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	5.80	gnl|BL_ORD_ID|434|hsp_num:0	465
NODE_41218_length_505_cov_1.07333_1 # 2 # 139 # -1 # ID=40489_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.471	NODE_41218_length_505_cov_1.07333_1 	2	139	-	Loose	1800	21.1718	mdtB	28.57	3000793	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAAATTATTCTGTTAGAAAAAATCGGTGGTTTGGGCAACTTGGGCGATATCGTAACCGTGAAAAACGGCTACGCCCGCAACTTCCTCATCCCGCAAGGTAAAGCCAAACGCGCAACAGAGGCCAATAAAGCCGAA	MQIILLEKIGGLGNLGDIVTVKNGYARNFLIPQGKAKRATEANKAE	MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA	4.42	gnl|BL_ORD_ID|778|hsp_num:0	820
NODE_419_length_7455_cov_2.93514_4 # 2238 # 2861 # 1 # ID=419_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.402	NODE_419_length_7455_cov_2.93514_4	2238	2861	+	Strict	400	427.172	tetR	100.0	3003479	protein overexpression model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCTAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAAGGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAAAATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCTTTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGTCATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAATCAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGGCATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCTACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCAGCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGGGTCTTAA	MSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	99.52	gnl|BL_ORD_ID|459|hsp_num:0	276
